Stay updated on CMP-001 and Nivolumab in Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the CMP-001 and Nivolumab in Advanced Melanoma Clinical Trial page.

Latest updates to the CMP-001 and Nivolumab in Advanced Melanoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page history shows an addition of Revision: v3.3.4 and a deletion of Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedAddition of Revision: v3.3.3 to the page footer; removal of HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision: v3.3.2 replaces Revision: v3.2.0 in the page history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check66 days agoChange DetectedRemoval of a site-wide banner about a lapse in government funding and operating status; this change does not affect the trial data, records, or study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check87 days agoChange DetectedThe new screenshot shows only minor visual/layout adjustments to the Record History page; core study details and statuses appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check109 days agoChange DetectedCore content updated: adds a funding-related operating-status notice and confirms NIH Clinical Center is open, plus a version upgrade to v3.2.0 and removal of v3.1.0.SummaryDifference10%

Stay in the know with updates to CMP-001 and Nivolumab in Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CMP-001 and Nivolumab in Advanced Melanoma Clinical Trial page.